文献速递角膜与眼表疾病眼整形与眼眶

Stevens-Johnson综合征视力丧失与手术干预的多中心全国队列预测因素

Predictors of Vision Loss and Surgical Intervention in Stevens-Johnson Syndrome: A Multicenter Nationwide Cohort Study.
PubMed 文献 · Am J Ophthalmol · 2026-09-18

该回顾性多中心队列分析228眼(115例)慢性SJS患者,就诊延迟中位1年,53.5%患眼接受手术。睑缘角化(LMK)与结膜化预测手术需求,病程长、系统免疫调节治疗及抗生素/NSAIDs暴露预测视力丧失。

要点

  • 慢性SJS常晚期就诊,53.5%患眼需手术,黏膜移植最常见(21.4%)。
  • LMK(aOR 11.5)与结膜化(aOR 2.8)预测手术需求。
  • 抗生素(aOR 3.9)与NSAIDs(aOR 4.8)暴露预测视力丧失。

核心结论

  • 慢性SJS常表现为晚期病变、频繁需要手术及进行性视力丧失。
  • 疾病慢性化及抗生素或NSAIDs暴露预测视力恶化,LMK与结膜化预测手术需求。
  • 转诊延迟与急性期治疗使用有限可能导致不良结局,强调需国家指南推动早期转诊与标准化诊疗。

研究设计与样本

  • 回顾性多中心临床队列研究,分析三级转诊中心病历。
  • 采用机器学习随机森林模型及多变量逻辑回归识别手术与视力丧失预测因素。
  • 共分析115例患者228眼。

主要发现

  • 就诊时表现包括浅层点状角膜炎(83.3%)、结膜充血(71.9%)、角膜缘干细胞缺乏(LSCD,59.2%)、睑球粘连(54.3%)、角膜新生血管(48.2%)、倒睫(47.3%)及睑缘角化(LMK,42.5%)。
  • 随访期间53.5%患眼接受手术,最常见为黏膜移植(21.4%)。
  • LMK(aOR 11.5,95%CI 3.56-36.92)与结膜化(aOR 2.8,95%CI 1.33-5.75)为手术需求预测因素。
  • 随访时间更长(aOR 1.4,95%CI 1.00-1.89)、使用系统免疫调节治疗(IMT,aOR 1.5,95%CI 1.08-2.17)、相关药物抗生素(aOR 3.9,95%CI 1.60-9.5)及NSAIDs(aOR 4.8,95%CI 1.58-14.77)为视力丧失预测因素。

关键数值与推荐

  • LMK的aOR为11.5(95%CI 3.56-36.92),结膜化的aOR为2.8(95%CI 1.33-5.75),均预测手术需求。
  • 随访时间aOR 1.4(95%CI 1.00-1.89)、IMT aOR 1.5(95%CI 1.08-2.17)、抗生素aOR 3.9(95%CI 1.60-9.5)、NSAIDs aOR 4.8(95%CI 1.58-14.77)均预测视力丧失。

临床怎么用

  • 对慢性SJS患者应关注LMK与结膜化以评估手术风险。
  • 需重视抗生素或NSAIDs暴露史及病程长度对视力丧失的预测意义。
  • 推动早期转诊与急性期标准化治疗可能减少不可逆视力损害。

局限性

  • 回顾性研究设计可能存在选择偏倚与信息偏倚。
  • 就诊延迟中位1年,可能影响预测因素的外推性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To identify presenting manifestations and clinical predictors of surgical intervention and progressive vision loss in chronic Stevens-Johnson syndrome (SJS). DESIGN: Retrospective, multicenter clinical cohort study. METHODS: Multicenter analysis of medical records from tertiary referral centers. Machine-learning-based random forest models, followed by multivariate logistic regression, were used to identify predictors of surgery and visual loss. RESULTS: A total of 228 eyes from 115 patients were analyzed. The median delay to presentation at specialized centers was 1 year. Findings at presentation included superficial punctate keratitis (83.3%), conjunctival hyperemia (71.9%), limbal stem cell deficiency (LSCD, 59.2%), symblepharon (54.3%), corneal neovascularization (48.2%), trichiasis (47.3%), and lid margin keratinization (LMK, 42.5%). During follow-up, 53.5% of eyes underwent surgery, most commonly mucous membrane grafting (21.4%). LMK (aOR: 11.5, 95% CI: 3.56-36.92) and conjunctivalization (aOR: 2.8, 95% CI: 1.33-5.75) were predictors of the need for surgery. Longer follow-up duration (aOR: 1.4, 95% CI: 1.00-1.89), use of systemic immunomodulatory therapy (IMT, aOR: 1.5, 95% CI: 1.08-2.17), and associated agents antibiotics (aOR: 3.9, 95% CI: 1.60-9.5) and NSAIDs (aOR: 4.8, 95% CI: 1.58-14.77) were predictors of vision loss. CONCLUSION: Chronic SJS often presents with advanced disease, frequent need for surgery, and progressive vision loss. Chronicity of disease and antibiotic or NSAID exposure predicted visual deterioration, while LMK and conjunctivalization predicted the need for surgery. Delayed referral and limited use of acute-phase therapies may contribute to poor outcomes, emphasizing the need for national guidelines for early referral, standardized care, and coordinated strategies to prevent avoidable vision loss.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Ortiz-Morales G, Barcelo-Canton RH, Rodriguez-Garcia A, et al. Predictors of Vision Loss and Surgical Intervention in Stevens-Johnson Syndrome: A Multicenter Nationwide Cohort Study. Am J Ophthalmol. 2026. PMID: 42759755. doi:10.1016/j.ajo.2026.09.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。